Article

Challenges and Limitations in Molecular Testing of Resected Non-Small Cell Lung Cancer Specimens

2026-03-30

Abstract excerpt

Non-small cell lung cancer (NSCLC) accounts for nearly 85% of lung cancer cases and remains a leading cause of cancer-related mortality worldwide. Advances in molecular diagnostics and targeted therapies have transformed treatment paradigms, yet the in-tegration of molecular testing into routine care for resected NSCLC specimens contin-ues to face significant challenges. This review outlines the technical, clinica...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 1ffc0013-3a94-5e12-ab93-03f5bd54a3a7
DOI: 10.20944/preprints202603.2351.v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Challenges and Limitations in Molecular Testing of Resected Non-Small Cell Lung Cancer SpecimensDOI 10.20944/preprints202603.2351.v1Read

Expert opinion on NSCLC small specimen biomarker testing - Part 2: Analysis, reporting, and quality assessment.Semantic proximity Read

Molecular Pathology of Lung Cancer.Semantic proximity Read

State of the Art of Pathologic and Molecular Testing.Semantic proximity Read

Recommendations for reporting tissue and circulating tumour (ct)DNA next-generation sequencing results in non-small cell lung cancerSemantic proximity Read

Molecular Diagnostics in Non-Small Cell Lung Carcinoma.Semantic proximity Read

The American Cancer Society National Lung Cancer Roundtable strategic plan: Challenges in clinical guideline recommendations for biomarker testing in lung cancer.Semantic proximity Read

Molecular Pathology of Lung Cancer.Semantic proximity Read

Updated Molecular Testing Guideline for the Selection of Lung Cancer Patients for Treatment With Targeted Tyrosine Kinase Inhibitors: Guideline From the College of American Pathologists, the International Association for the Study of Lung Cancer, and the Association for Molecular Pathology.Semantic proximity Read

Molecular testing in lung cancer: fine-needle aspiration specimen adequacy and test prioritization prior to the CAP/IASLC/AMP Molecular Testing Guideline publication.Semantic proximity Read

Molecular pathology of non-small cell lung cancer: a practical guide.Semantic proximity Read

Lung cancer cytology and small biopsy specimens: diagnosis, predictive biomarker testing, acquisition, triage, and management.Semantic proximity Read

Molecular testing and targeted therapy for non-small cell lung cancer: Current status and perspectives.Semantic proximity Read